DTaP-IPV/Hib vaccine

DTaP-IPV/Hib vaccine
Combination of
DTaP vaccine Vaccine
Inactivated poliovirus vaccine Vaccine
Hib vaccine Vaccine
Clinical data
Trade names Pentacel, Pediacel, Infanrix IPV + Hib, Pentaxim
AHFS/Drugs.com Pentacel
Pregnancy
category
  • US: C (Risk not ruled out)
    Routes of
    administration    		 Intramuscular injection
    ATC code

    DTaP-IPV/Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and haemophilus B conjugate (tetanus toxoid conjugate) vaccine.[1] It is also known as DTaP-IPV/Hib or DTaP-IPV-Hib. It protects against the infectious diseases diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type B.

    A branded formulation marketed in the USA is Pentacel, manufactured by Sanofi Pasteur.[2] Pentacel is known in the UK and Canada as Pediacel. An equivalent vaccine marketed in the UK and Canada by GlaxoSmithKline is Infanrix IPV + Hib. This is a two-part vaccine. The DTaP-IPV component is supplied as a sterile liquid, which is used to reconstitute lyophilized (freeze-dried) Hib vaccine.

    Pentaxim is a liquid formulation marketed by Sanofi Pasteur.

    References

    1. ↑ "Diphtheria and Tetanus Toxoids, Acellular Pertussis, Poliovirus and Haemophilus b Conjugate Vaccine". Drugs.com. Retrieved 15 July 2018.
    2. ↑ "Pentacel". US Food and Drug Administration. Retrieved 15 July 2018.


    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.